European Organisation for Research and Treatment of Cancer - EORTC clinical trials
Listed in the registry as: Research network.
The registry lists 352 studies whose lead sponsor is European Organisation for Research and Treatment of Cancer - EORTC. 23 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.
Keep track of what changes. Save the European Organisation for Research and Treatment of Cancer - EORTC studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions European Organisation for Research and Treatment of Cancer - EORTC leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 352. Browse all 352 →
- PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)RecruitingNCT04790253Not applicable
- Vorasidenib Maintenance for IDH Mutant AstrocytomaRecruitingNCT06809322Phase 3
- Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)RecruitingNCT05512364Phase 3
- Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaRecruitingNCT04031677Phase 3
- Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 StudyRecruitingNCT06990061Not applicable
- Eortc MoBilE Device (EMBED)Not yet recruitingNCT07711080
- Adjuvant Tebentafusp in High Risk Ocular MelanomaRecruitingNCT06246149Phase 3
- SPECTA: Screening Cancer Patients for Efficient Clinical Trial AccessRecruitingNCT02834884
- 177Lu-DOTATATE for Recurrent MeningiomaRecruitingNCT06326190Phase 2
- Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III StudyRecruitingNCT05904119Phase 3
- Radiopharmaceutical Treatment of Advanced Kidney CancerRecruitingNCT06783348Phase 2
- Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain MetsNot yet recruitingNCT07234877Phase 2
- Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck CancerRecruitingNCT05815927Phase 3
- FLT3-ITD Targeted Therapy in Fit AML PatientsNot yet recruitingNCT07425808Phase 2/3
- Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO ClassificationRecruitingNCT05259605
- Intermittent Androgen Deprivation Therapy in the Era of AR Pathway InhibitorsRecruitingNCT05974774Phase 3
- OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)RecruitingNCT06462963Not applicable
- Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative TreatmentNot yet recruitingNCT06978062Phase 1
- E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for EuropeRecruitingNCT03818503
- Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast CancerNot yet recruitingNCT06407401Phase 3
- Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)RecruitingNCT04498767Not applicable
- Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder CancerNot yet recruitingNCT06310369Phase 2
- Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell LymphomaRecruitingNCT04128072Phase 2
- Follow-up in Gynecological Cancer SurvivorsActive, not recruitingNCT03515993
- Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II StudyActive, not recruitingNCT03517137Phase 2
- Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaTerminatedNCT05724602Phase 2
- Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLCActive, not recruitingNCT06219317Phase 2
- Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE)CompletedNCT02856893Phase 2
- Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate CancerActive, not recruitingNCT02799706Phase 3
- Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)Active, not recruitingNCT03134118Phase 2
- Male Breast Cancer: Understanding the Biology for Improved Patient CareActive, not recruitingNCT01101425
- Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast CancerCompletedNCT00062400Not applicable
- Follow-up in Early and Locally Advanced Breast Cancer PatientsCompletedNCT03859453
- Adjuvant Palbociclib in Elderly Patients With Breast CancerActive, not recruitingNCT03609047Phase 2
- Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.CompletedNCT03224104Phase 1
- Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed MedulloblastomaTerminatedNCT04402073Phase 2
- ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate CancerActive, not recruitingNCT02972060Phase 2
- Nintedanib as Switch Maintenance Treatment of Pleural Malignant MesotheliomaTerminatedNCT02863055Phase 2
- Phase III Radium 223 mCRPC-PEACE IIIActive, not recruitingNCT02194842Phase 3
- SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial AccessCompletedNCT02214134
- Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal CarcinomaActive, not recruitingNCT02984410Not applicable
- RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's DiseaseActive, not recruitingNCT00002462Phase 3
- Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's LymphomaCompletedNCT00049595Phase 3
- Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's LymphomaActive, not recruitingNCT00379041Phase 3
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's LymphomaActive, not recruitingNCT00005584Phase 3
- IRCI Gynae Sarcomas, High Grade Uterine SarcomaCompletedNCT01979393Phase 2
- Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and BinimetinibActive, not recruitingNCT03235245Phase 2
- Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT02205047Phase 2
- Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare StudyWithdrawnNCT06347185Not applicable
- Trabectedin for Recurrent Grade II/III MeningiomaCompletedNCT02234050Phase 2